Mario Arangio

Mario Arangio is a skilled professional in the pharmaceutical and biotech sectors, currently serving as the Head of Pharmaceutical Development at Aenova Group since November 2018, where responsibilities include the development and production of Soft Gelatine Capsules formulations and oversight of cGMP compliance for R&D. Prior freelance experience from September 2017 to October 2018 involved consultancy in Life Sciences, focusing on product strategy and innovation management. Mario's prior roles include Director of Product Management and Partnering at Hamilton Bonaduz AG, where strategic development and B2B partnerships were key tasks, and Head of Analytical Development at Carbogen Amcis, overseeing a significant business unit and managing multiple analytical development groups. Additional experience includes senior roles at Pfizer and ArQule, Inc., contributing to drug discovery and high throughput technologies. Mario holds a Ph.D. in Analytical Chemistry from Universität des Saarlandes and a Marketing Certificate from the University of St.Gallen.